James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

4 Biotech Stocks to Buy

If this August is like most Augusts, the overall market isn't going to perform well for the next few weeks; biotech stocks may be the only worthwhile stocks to buy

NLRB Ruling on McDonald’s Puts Franchising Stocks in Jeopardy

The recent ruling by the National Labor Relations Board is likely to cause a ripple effect on the franchising model.

FB Vs. TWTR Stock: Was Q2 a Game-Changer for Twitter?

Don't look now, Facebook, but Twitter may now be where you were a year ago ... and that could be great news for TWTR stock owners.

Can We Trust Silver’s Leadership Over Gold?

The iShares Silver Trust (SLV) has outpaced the SPDR S&P 500 ETF Trust (SPY) since early June. Do we take the hint?

3 Reasons Why the S&P 500 Is About to Correct

The S&P 500 is now within striking distance of the psychologically important 2000 mark, but the stage also has been set for a correction.

Amazon Wallet is Just a Small Part of Threat to Big Banks

Amazon Wallet is only one of many reasons big banks and owners of bank stocks need to worry.

Surprise! 4 Tech Stocks Becoming Medical Tech Names

The face of medical tech is increasingly becoming a blend of healthcare stocks and tech stocks. Here are four stocks melding the best of both worlds.

Apple Investors Can Ignore the China Central Television Warning

China Central Television tried to scare Chinese consumers away from the Apple iPhone, but such past efforts have actually backfired.

Gold Prices Poised to Continue Their Breakdown

Gold prices got the rug pulled our from underneath them on Monday, and history says they're on the verge of an even bigger dip.

What Yahoo Stock Needs From Tuesday’s Earnings Report

The Yahoo stock price trend hasn't been encouraging since the beginning of 2014, but Tuesday's YHOO earnings report could change that.